Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Dr. Bitterman is a physician-scientist with a research interest at the intersection of oncology, natural language processing, and clinical implementation of artificial intelligence technologies. She also has an interest in the bioethical considerations of artificial intelligence development and deployment. Dr. Bitterman's goals are to advance cancer research by taking full advantage of robust real-world data to uncover previously unidentified clinical trends, and to integrate advanced informatics technologies into clinic in a safe, patient-centered fashion.
Dr. Bitterman received her undergraduate degree at Columbia University, and attended medical school at New York University School of Medicine. She completed an internship in internal medicine at the Brigham and Women's Hospital, and her residency at the Harvard Radiation Oncology Program.
Dana-Farber Cancer Institute450 Brookline AvenueBoston, MA 02215Get Directions